Condensed consolidated statement of cash flows

for the period ended 31 March 2016

Download (EXCEL)


R’m
6 months
31 March
2016
  %
Change
  6 months
31 March
2015
  12 months
30 September
2015
 
Cash generated from operations 1 625   7.2   1 516   3 842  
Tax paid (398)       (401)   (903)  
Net cash generated from operating activities 1 227   10   1 115   2 939  
Capital expenditure (345)       (368)   (1 181)  
Investments (989)       (1 867)   (1 933)  
Other (9)       (49)   (104)  
Net cash utilised in investing activities¹ (1 343)       (2 284)   (3 218)  
Interest-bearing borrowings raised 1 655       2 510   4 268  
Interest-bearing borrowings repaid (767)       (619)   (1 860)  
Distributions to shareholders (666)       (814)   (1 520)  
Other (435)       (400)   (654)  
Net cash utilised in financing activities (213)       677   234  
Net Decrease in cash and cash equivalents (329)       (492)   (45)  
Cash and cash equivalents – beginning of the period 255       267   267  
Cash balances acquired through business combinations 54       19   20  
Effect of foreign currency movement (46)       5   13  
Cash and cash equivalents – end of the period (66)       (201)   255  
1 The cash utilised in investing activities includes the acquisitions in Poland (R669 million), and the additional investment in Max Healthcare Institute Limited, India for R320 million.